D. Boral Capital Maintains MediciNova (MNOV) Buy Recommendation
I'm PortAI, I can summarize articles.
D. Boral Capital has maintained a Buy recommendation for MediciNova (MNOV). The average one-year price target suggests a 357.69% upside, with institutional ownership showing some increases in certain funds, though overall shares owned by institutions decreased. The put/call ratio indicates a bullish outlook for the stock.
Source: Nasdaq The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments